Search

for
Search:

GlossaryInduced Pluripotent Stem Cells (iPS cells)

cells reprogrammed from adult cells to an embryonic-like state

Induced Pluripotent Stem Cells (iPSCs) are a type of stem cell that scientists create by reprogramming adult cells, such as skin or blood cells, to revert to an embryonic-like state. This process allows these cells to potentially develop into any type of cell in the body, making them valuable for research, regenerative medicine, and disease modeling.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 269 results

research Human Hair Follicle Pluripotent Stem Cells Promote Regeneration of Peripheral Nerve Injury: An Advantageous Alternative to ES and iPS Cells

121 citations , June 2009 in “Journal of Cellular Biochemistry”

Human hair follicle stem cells can safely and effectively help nerve regeneration.

research Bioengineering a 3D Integumentary Organ System from iPS Cells Using an In Vivo Transplantation Model

77 citations , April 2016 in “Science Advances”

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

research Generation of iPS Cells from Human Hair Follicle Dermal Papilla Cells

15 citations , March 2014 in “Acta naturae”

Researchers made stem cells from human hair follicle cells with higher efficiency than from skin cells.

research Regeneration of a Bioengineered 3D Integumentary Organ System from iPS Cells

12 citations , April 2019 in “Nature protocols”

Scientists created a functional 3D skin system from stem cells that can be transplanted into wounds.

research Generation of iPS Cells from Human Hair Follicle Dermal Papilla Cells

8 citations , January 2014 in “PubMed”

Researchers made stem cells from human hair follicle cells with better efficiency than from skin cells.

View more "ips cells" in research →

Community Join

3 / 3 results

community Dr. Tsuji and Riken to make important announcement on their hair cloning cure on Feb 10th.

in Update 57 upvotes 4 years ago

Dr. Tsuji and Riken announced a hair cloning cure with a 98.9% success rate, expected to be released in 10 years. Users expressed hope and skepticism about the affordability and timeline of the treatment.

community Is there any word on when Stempsen Therapeutics and Hairclone will start phase 1 clinical trials?

in Research/Science 6 upvotes 3 years ago

Hair cloning trials by Stempsen Therapeutics and Hairclone have no updates, and it may take at least 15 years for hair cloning to be available. The conversation also mentions treatments like Minoxidil, finasteride, and RU58841.

community Prediction: Scube3 is never coming out

in Research/Science 6 upvotes 1 year ago

Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.